On June 5–6, the Global Think-tank on Steatotic Liver Disease convened a multidisciplinary group of 125 participants in Barcelona, including clinicians, patient advocates, public health experts, and industry representatives, to connect science, policy, care, and people in advancing global recognition of steatotic liver disease (SLD). AACE President Scott D. Isaacs, MD, FACP, FACE, a key author of the Think-tank’s recent Lancet policy publication, joined experts in calling for integrated, person-centered strategies to address MASLD and MASH through multidisciplinary collaboration.